Zaher Fanari

Zaher Fanari, MD is an Associate Professor of Cardiology at the University of California, San Francisco (UCSF) Fresno, serving as Director of Interventional Cardiology and Director of Structural Heart Disease. He completed his medical degree at the University of Aleppo, followed by training in Internal Medicine at Saint Louis University, Cardiovascular Diseases at Thomas Jefferson University, Interventional Cardiology at the University of Kansas, and Structural/Endovascular Cardiology at the Prairie Heart Institute. His clinical expertise includes complex PCI, structural heart interventions (TAVR, MitraClip, Watchman), and vascular procedures. Dr. Fanari has received numerous awards, including ACC Young Investigator Finalist (2015) and Top Abstract honors at CRT (2016-2017).

Education & Training:

• Doctor of Medicine, University of Aleppo (2006)
• Internal Medicine Residency, Saint Louis University (2012)
• Cardiovascular Fellowship, Thomas Jefferson University/Christiana Care (2015)
• Interventional Cardiology Fellowship, University of Kansas (2016)
• Structural/Endovascular Training, Prairie Heart Institute (2017)

Research Interests: Focuses on transcatheter valve therapies, structural heart disease interventions, and vascular medicine. His work includes meta-analyses on TAVR outcomes in diverse patient populations and innovations in device retrieval techniques. He is board certified in multiple specialties including Interventional Cardiology and Vascular Medicine.

Awards & Recognition:

• ACC Young Investigator Finalist (2015)
• Top 15 Abstract Award, CRT 2016
• Top 30 Abstract Award, CRT 2017
• ASE Travel Grant (2016)
• Focus on Excellence Clinical Award (2015)

Leadership Roles: Serves on multiple committees within the American College of Cardiology (ACC), including the Structural Heart Disease Working Group and CHIP Patient Navigation Program. Active in authoring over 65 manuscripts and textbook chapters, including contributions to Topol's Interventional Cardiology Textbook.

Labs & Teams: Leads structural heart disease programs at UCSF Fresno, emphasizing minimally invasive therapies and complex case management.